🔴 HCW Biologics is trading 5.3% down in pre-market amid apparent profit-taking after consecutive gains

HCW Biologics is trading at $3.40, down 5.29% in pre-market amid apparent profit-taking after a sharp multi-session rally.

• No new company-specific announcement dated August 31, 2026, was identified; latest releases concern second-quarter results and clinical-development updates.
• Shares rose from $2.18 on August 21 to $3.59 on August 31, supporting the profit-taking explanation.
• Broader markets are modestly weaker but do not clearly explain the larger decline.